The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
Revance Therapeutics Inc (NASDAQ: RVNC) closed the day trading at $5.78 down -0.52% from the previous closing price of $5.81. In other words, the price has decreased by -$0.52 from its previous closing price. On the day, 0.98 million shares were traded. RVNC stock price reached its highest trading level at $5.9 during the session, while it also had its lowest trading level at $5.73.
Ratios:
For a better understanding of RVNC, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.01 and its Current Ratio is at 3.74.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Mizuho on January 29, 2024, Downgraded its rating to Neutral and sets its target price to $9 from $16 previously.
On January 09, 2024, Goldman Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $30 to $8.
Exane BNP Paribas Upgraded its Underperform to Neutral on August 16, 2023, while the target price for the stock was maintained at $20.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 16 ’24 when Jordan Erica sold 2,392 shares for $3.80 per share. The transaction valued at 9,096 led to the insider holds 114,864 shares of the business.
Sjuts Dustin S sold 9,211 shares of RVNC for $46,446 on Mar 18 ’24. The President now owns 167,550 shares after completing the transaction at $5.04 per share. On Mar 18 ’24, another insider, Moxie Dwight, who serves as the CLO & GC of the company, sold 8,125 shares for $5.04 each. As a result, the insider received 40,971 and left with 137,815 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RVNC now has a Market Capitalization of 605287424 and an Enterprise Value of 865270848. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.47. Its current Enterprise Value per Revenue stands at 3.445 whereas that against EBITDA is -4.505.
Stock Price History:
Over the past 52 weeks, RVNC has reached a high of $9.74, while it has fallen to a 52-week low of $2.30. The 50-Day Moving Average of the stock is 1.12%, while the 200-Day Moving Average is calculated to be 23.39%.
Shares Statistics:
Over the past 3-months, RVNC traded about 4.62M shares per day on average, while over the past 10 days, RVNC traded about 2117180 shares per day. A total of 104.18M shares are outstanding, with a floating share count of 95.04M. Insiders hold about 8.78% of the company’s shares, while institutions hold 64.79% stake in the company. Shares short for RVNC as of 1728950400 were 9194558 with a Short Ratio of 1.99, compared to 1726185600 on 7631413. Therefore, it implies a Short% of Shares Outstanding of 9194558 and a Short% of Float of 10.14.
